ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGY Allergy Therapeutics Plc

3.00
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Allergy Therapeutics Plc LSE:AGY London Ordinary Share GB00B02LCQ05 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.00 2.80 3.20 3.00 3.00 3.00 81,490 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 59.59M -43.07M -0.0090 -3.33 142.99M
Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 3p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 0.85p to 3.80p.

Allergy Therapeutics currently has 4,766,439,938 shares in issue. The market capitalisation of Allergy Therapeutics is £142.99 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -3.33.

Allergy Therapeutics Share Discussion Threads

Showing 3576 to 3600 of 5000 messages
Chat Pages: Latest  152  151  150  149  148  147  146  145  144  143  142  141  Older
DateSubjectAuthorDiscuss
11/10/2018
08:46
This is either an amazing buying opportunity or there is something they are not telling us.
mobox1
08/10/2018
18:12
Yes I agree. A pretty bad day for most shares. The lemming factor is always a pain in the butt.
jammyjim
08/10/2018
18:03
Sentiment across the market and nothing more I feel.

The Lemming factor!

impo.

jimmyloser
08/10/2018
17:48
Quite a few buys came in at a lower price so hopefully it will go back to what it was previously. I can’t find any News on other boards to see what the problem was.
jammyjim
08/10/2018
14:33
What's happenned here? Why the sudden drop, is there bad news about one of the trials
richsawko
26/9/2018
09:42
Morning. Short TV interview with the guys following this morning's results announcement:

www.fmp-tv.co.uk/2018/09/26/increased-market-share-and-revenues-at-allergy-therapeutics/

oshy92
26/9/2018
06:42
Solid. Phase III birch results will be key. Seems like news flow will shift from 4Q 2018 to 3Q 2019
audigger
26/9/2018
06:22
Well done all at AGY.

Now we climb the big one!

jimmyloser
25/9/2018
15:47
Not much volume today and flat share price Lets see what tomorrow brings!
audigger
21/9/2018
16:23
No sign of any confidence here after last year.
Impo

jimmyloser
21/9/2018
16:12
All quiet this week. May be different next week!
audigger
11/9/2018
08:07
Have added; this is now my biggest share holding so am hoping for good news on Sept 26!
audigger
07/9/2018
12:20
Some patience required as it isn't going to fly until we get good results from the ongoing trials. Update coming in a few weeks times; remains to be seen whether any key trial findings will be announced.
audigger
03/9/2018
10:57
This was always a share for the long haul though, wasn't it?

I've said every year for the past few years, this year or I'm out, but haven't been able to press that sell button.

aruntim
24/8/2018
16:42
I certainly hope that they do.
I also agree with you with much of what you say.
This year or I am out. We have had too many setbacks impo.

jimmyloser
24/8/2018
16:12
This has got to qualify as one of my most boring shares! At the exact level it was three years ago and no divi, so a loser in a bull market :( .Guess the BOD still get paid handsomely at our expense eh!
jpuff
22/8/2018
09:44
Hi farmergeorge,

As to broker forecasts Numis is 45p and FinnCap 43p. FWIW my short-term target is 35p and long-term 260p.

Regards, Maddox

maddox
22/8/2018
09:29
Hi AD,

Yep, typical share price drift in the absence of news. Good opportunity to pick up some additional stock before 26th Full Year Update. The previous year's tree and hay fever season was very mild - this year certainly wasn't - as I can personally vouch for. So the results should hopefully reflect this - good sales versus a soft comparative prior period.

I'm doing some house-keeping moving my holding from dealing account to ISA - so will add more in the process. When FDA approval comes through I certainly don't want these to be subject to CGT.

Regards, Maddox

maddox
22/8/2018
08:31
All quiet here. Contemplating a modest top-up ahead of what should be an interesting Q3/Q4. One would think demand would have been high this year compared to last given the weather and impact on pollen.
audigger
22/7/2018
21:44
What is the latest broker forecast for the sp? Thanks.
farmergeorge
19/7/2018
10:50
Yes, earlier than expected but good tactics to raise funds on the back of positive news. If new investors are brought on board it can lead to a price rise as they look to accumulate their desired position.
maddox
19/7/2018
06:28
Funding was expected but this is sooner than I imagined which I think is a good thing given the ever-expanding business opportunities and the intention to accelerate product development. May not be much impact on the share price and the placing price is encouraging
audigger
19/7/2018
06:16
TRANSFORMATIONAL!
jimmyloser
12/7/2018
11:52
Solid. Suspect 2018 has been rather more pollen rich than 2017. Q4 2018 looks to be a defining period for AGY
audigger
12/7/2018
06:30
Agreed Rich/ it is those trial results that will set this alight!

Timed to come on or about results statement in September?

impo/dyor

jimmyloser
Chat Pages: Latest  152  151  150  149  148  147  146  145  144  143  142  141  Older

Your Recent History

Delayed Upgrade Clock